Curious, hard-driven and meticulous, I am a seasoned B2B journalist specializing in pharma and medical device regulations and healthcare policy. Currently, I am an executive editor for FDAnews in Falls Church, Va.
Over the years, I’ve covered the FDA, Capitol Hill, NIH, Wall Street IPOs and analyst meetings, drug and device pipeline, Medicare and Medicaid, the Children’s Health Insurance Program, managed healthcare, hospital utilization trends and clinical research. For the past seven years, I’ve focused largely on foreign regulatory policy in markets ranging from the EU, Canada, Australia and Japan to China, India and emerging economies in Latin America, Southeast Asia, Africa and the Middle East. Counterfeit and supply chain issues, global and regional harmonization, biosimilars, postmarket vigilance and cold chain problems in developing nations are all topics I’ve followed and continue to write about — combining the facts with historical perspective.
To keep life interesting, I also write mainstream, human interest and sometimes offbeat articles, like one on the national tick collection and the return home of a Liberian exile to restart his newspaper — the first independent daily in the country.
My skills include investigative reporting, substantive editing, an in-depth knowledge of the drug and device industries, crisp and compelling copy, the ability to turn stories around on tight deadlines, and social media.
In my spare time, I do photography, run and enjoy the outdoors.